CARFILNAT 60MG INJ
Prescription Required
Sale price
₹ 5,700.00
Regular price
MRP: ₹ 9,365.60
39% OFF
Inclusive of all taxes.
Couldn't load pickup availability
CARFILNAT 60MG INJ
Regular price
₹ 5,700.00
Regular price
₹ 9,365.60
Sale price
₹ 5,700.00
(-39%)
Unit price
per
CARFILNAT 60MG INJ
Sale price
₹ 5,700.00
Regular price
MRP: ₹ 9,365.60
39% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Carfilnat 60mg Injection contains carfilzomib, a proteasome inhibitor that blocks protein degradation in cancer cells, leading to tumour cell death.
Uses
Carfilnat 60mg Injection is used for the treatment of multiple myeloma.
- Relapsed multiple myeloma.
- Refractory multiple myeloma in adults.
Storage
- Store refrigerated at 2°C–8°C.
- Protect from light.
- Do not freeze.
Safety Information
- Monitor heart function, kidney function and blood counts during treatment.
- Inform your doctor about heart disease or infections before therapy.
Possible Side Effects
Possible side effects may include:
- Fatigue
- Anaemia
- Low platelet count
- Nausea
- Fever
- Breathlessness
- Diarrhoea
- High blood pressure
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Carfilnat is a prescription anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.